About Us
Premium Insights
Expert Views
Compliance
Experts
Careers
Contact Us
Experienced Biopharmaceutical Professional | Former Head of Section - Biologics Cell Line, Viral Vector, mRNA Therapeutics Development (Jan 2021 - Dec 2022)
Tier 1Syngene International Limited, India
This author has not provided additional details yet.
Contact: +91 NA
The article analyzes biopharma’s cell line development, AI-driven innovation, CGT manufacturing shifts, mRNA regulatory challenges, and key investor questions shaping …
May 14, 2025